Search

  • Sort by

  • Category

  • Post Type

  • Reset

Counterfeit Cancer Medication Found in U.S.

February 14, 2012
Posted in

A counterfeit version of Avastin cancer therapy has been found in the U.S. announced manufacturer Roche Holding AG, a Swiss company.

Vials of the medication were tested by Roche and found to not contain the active ingredients, according to Roche’s Genentech unit, reported The Wall Street Journal.

Read More

Alert: Unapproved Drug Found in RegenArouse, Recalled by Maker

February 13, 2012
Posted in ,

This is a reprint of the FDA alert. Regeneca, Inc. announced today that it is conducting a voluntary nationwide recall of RegenArouse, Lot Number 130100, because FDA lab analysis has confirmed the presence of Tadalafil making these products unapproved new drugs. Tadalafil is an FDA-approved drug used as treatment for male Erectile Dysfunction (ED). The active drug ingredient is not…

Read More

British Men Sentenced for Illegal Online Sale of Pharmaceuticals

February 10, 2012
Posted in

Clemsford Crown Court sentenced two men who pleaded guilty to advertising and selling prescription only medicines on websites. The two Essex residents, Steven Corbersmith, 35, from Frinton-on-Sea, and Stefa Hazell, 28, from Kirby-le-Soken. ran two websites that illegally sold prescription only medications clomiphene citrate, used for fertility enhancement, and anabolic steroids, reported the UK’s Medicines and Healthcare Products Regulatory Agency…

Read More

Liang BA*, & Mackey TK, Online Availability and Safety of Drugs in Shortage: A Descriptive Study of Internet Vendor Characteristics. J Med Internet Res. 2012 Feb 9;14(1):e27.

February 9, 2012
Posted in , , ,

ABSTRACT  Background: Unprecedented drug shortages announced by the US Food and Drug Administration (FDA) have severely affected therapeutic access, patient safety, and public health. With continued shortages, patients may seek drugs online. Objective: To assess the prevalence of online marketing for current FDA shortage drugs and potential patient safety risks. Methods: We performed a descriptive study of the prevalence of online marketing for…

Read More

AstraZeneca Backs Counterfeit Drug Penalty Legislation in US Congress

January 20, 2012
Posted in ,

On January 19, 2012, AstraZeneca sent members of Congress a letter supporting legislation to increase penalties for counterfeit prescription drug crime.

The letters were sent to Senator Patrick Leahy (D-VT), Senator Chuck Grassley (R-IA), Representative Linda Sanchez (D-CA), and Representative Patrick Meehan (R-PA), bill sponsors along with Senator Michael Bennet (D-CO) and Senator Richard Blumenthal (D-CT.).

Read More

Fake Antimalarial Drugs Endangering Millions, Killing Children and Pregnant Women

January 20, 2012
Posted in

The most potent anti-malarial drug has been found in counterfeit version in 11 African countries. On top of not curing patients sick with deadly malaria, lower than therapeutic doses of the active ingredient artemisinin in the fake meds can cause the parasites to develop resistance to the medication. In essence, the counterfeit drugs are likely to cause a mutation in the parasite, creating a newer, deadlier version of malaria not able to be cured by any known medication.

Read More

Peddling Poison Video

January 9, 2012
Posted in
Read More

Peddling Poison: The Counterfeit Drug Problem in America

January 9, 2012
Posted in

The Partnership for Safe Medicines released a video about the recent conviction of counterfeit drug seller Manuel Calvelo on youtube. The video, available here, is narrated by counterfeit medicine victim Rick Roberts, a patient advocate who has spoken about his experience receiving vital life-saving medicines that turned out to be fakes in front of Congress and at the Interchange.

Roberts explains the case of Manuel Calvelo, a Belgian citizen who ran numerous online fake pharmacies that sold so-called generic versions of non-generic drugs that claimed to treat serious health concerns, such as a heart disease, stroke and diabetes. Instead the medicines were tested and found to be fakes by FDA agents.

Read More
Excerpt of Maxine Blount's Obituary, St. Louis Post-Dispatch, October 28, 2002

Missouri Businesswoman Dies After Fake Anemia Drugs Delay Cancer Treatments

January 1, 2012
Posted in

In March 2002, oncology nurses in Missouri at discovered that their patient, Maxine Blount, had been taking Procrit that was only one-twentieth the strength it should have been. The counterfeit did not treat her anemia, leading to delays between chemotherapy infusions that allowed her cancer to advance much more rapidly. She died in October 2002.

In 2005, her brother testified before Congress: if her drugs had been genuine “she would have lived longer…experienced much less pain and suffering, and have been able to spend more time with her family.”

Read More

psm-india2.jpg

December 27, 2011
Read More